Predictors of Survival in Favorable Risk Patients with Metastatic Renal Cell Carcinoma Treated with a Single-Agent First-Line Therapy

INTRODUCTION: The aim of this retrospective study was to elucidate predictors of survival in metastatic renal cell carcinoma (mRCC) patients in an International Metastatic Renal Cell Carcinoma Database Consortium favorable risk group treated with frontline therapy without immune checkpoint inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Ryuichi, Takamatsu, Kimiharu, Yasumizu, Yota, Tanaka, Nobuyuki, Takeda, Toshikazu, Morita, Shinya, Matsumoto, Kazuhiro, Kosaka, Takeo, Asanuma, Hiroshi, Mikami, Shuji, Oya, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811414/
https://www.ncbi.nlm.nih.gov/pubmed/35139522
http://dx.doi.org/10.1159/000521960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811414/
https://www.ncbi.nlm.nih.gov/pubmed/35139522
http://dx.doi.org/10.1159/000521960

Ejemplares similares